Statements such as 'joint symptoms are characteristically acute, short-lived, and transient' 330 may give the patient and physician a false expectation. For the occasional, fortunate individual Reiter's syndrome (RS) may be a self-limiting disease. In fact, the prognosis of RS is notoriously difficult to assess. The reasons for this are protean. (1) Many patients are young men who form a mobile population and long-term follow-up is difficult. (2) In many patients, especially women, the disorder is misdiagnosed as 'seronegative rheumatoid arthritis' rather than RS. (3) Often the early classical stigmata of RS are forgotten and one is left with a patient complaining of a persistent arthropathy and perhaps spinal disease. The diagnosis of 'ankylosing spondylitis' is used. (4) Medical care is fragmentary; patients may be followed up by the orthopaedic surgeon, ophthalmologist, or other specialists. Long-term follow-up studies are therefore few and suffer from the inherent problem that they are usually performed in academic centres where patients with more severe disease are followed up.
Review of studies
A review of reported studies suggests that the prognosis of RS is relatively poor. The original Paronen epidemic244 in 1944, which affected 344 patients, was reviewed 20 years later,267 when 100 patients were available for study (no doubt including a bias towards those with more severe disease). Eighty of these patients still had active disease, which included 32 with ankylosing spondylitis, 18 with recurrent acute arthropathy, 30 with chronic joint disease, 7 with recurrent uveitis, and 2 with aortic regurgitation. Some 40 (over 10 % of the original RS patients) were unable to work because of persistent RS.
Csonka (see preceding paper, p. 24) followed up 185 patients for a period of 2 to 15 years. Sixty-two per cent had active disease, and he suggested a recurrence rate of 15 % per patient per year. Good133 followed up 34 patients for 2 years: 24 had persistent disease at the end of the period, including 13 with sacroiliitis. Our follow-up55 of Noer's original study238 revealed that four of the five patients contacted had active and severe disease 13 years after the original epidemic. All four had persistent joint problems, two had deteriorating vision after iridocyclitis, and two had ankylosing spondylitis. Only one remained free from active disease. Of interest, this patient was the only one ofthefivewho was HLA-B27 negative. McClusky et a1217 have also suggested that patients with HLA-B27 are more likely to develop severe disease.
Our study
Our more recent study,53 however, throws some doubt on this concept. In this investigation 113 patients were consecutively admitted to the study at both a university and a community medical centre in order to avoid selection bias (see Table 1 for diagnostic criteria). At a mean of 6 4 years 104 patients (93 %) were available for follow-up. In summary, there were no major differences between the two centres. There was little difference between men and women with RS or between B27-positive and negative patients (in contrast to our expectations).
The functional status at follow-up is shown in Table 2 . Features at entry to the study were compared with these at follow-up examination (Figure) . Polyarthritis persisted in 83 % of cases, urethritis or cervicitis, or both, in 42 %, back pain and heel pain in about 50%, eye disease in 33%, balanitis and mouth ulcers in 25 %, and other manifestations as 
